Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
46.12
-0.58 (-1.24%)
At close: Aug 6, 2026, 4:00 PM EDT
46.74
+0.62 (1.34%)
Pre-market: Aug 7, 2026, 7:34 AM EDT
Tempus AI Revenue
Tempus AI had revenue of $382.49M in the quarter ending June 30, 2026, with 21.56% growth. This brings the company's revenue in the last twelve months to $1.43B, up 50.43% year-over-year. In the year 2025, Tempus AI had annual revenue of $1.27B with 83.41% growth.
Revenue (ttm)
$1.43B
Revenue Growth
+50.43%
P/S Ratio
5.81
Revenue / Employee
$376,847
Employees
3,800
Market Cap
8.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.27B | 578.39M | 83.41% |
| Dec 31, 2024 | 693.40M | 161.58M | 30.38% |
| Dec 31, 2023 | 531.82M | 211.15M | 65.85% |
| Dec 31, 2022 | 320.67M | 62.82M | 24.36% |
| Dec 31, 2021 | 257.85M | 69.85M | 37.15% |
| Dec 31, 2020 | 188.00M | 125.95M | 202.95% |
| Dec 31, 2019 | 62.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BrightSpring Health Services | 14.37B |
| Veeva Systems | 3.32B |
| Privia Health Group | 2.25B |
| HealthEquity | 1.34B |
| Omnicell | 1.25B |
| Waystar Holding | 1.21B |
| Hinge Health | 646.34M |
| Doximity | 644.86M |
TEM News
- 22 hours ago - Tempus AI added to CellCarta’s CDx commercialization lab network - TheFly
- 22 hours ago - CellCarta Adds Tempus to CDx Commercialization Lab Network - PRNewsWire
- 2 days ago - Personalis says not providing guidance or conducting earnings call - TheFly
- 2 days ago - Tempus AI announces study results of PRISM2 - TheFly
- 2 days ago - Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications - Business Wire
- 3 days ago - Tempus AI price target lowered to $56 from $58 at Piper Sandler - TheFly
- 3 days ago - Tempus AI price target lowered to $70 from $80 at BTIG - TheFly
- 3 days ago - Tempus AI price target lowered to $56 from $64 at H.C. Wainwright - TheFly